NEW YORK (GenomeWeb News) — TEMIS today said Bayer HealthCare will use its text-analytics software in its drug-discovery programs.
The software, called Luxid for Life Sciences, addresses information-management problems “through automated domain-specific knowledge extraction, flexible analytics, documents classification, relationships representation and retrieval capabilities,” TEMIS said.
Bayer HC’s information services team will use the software to conduct searches of the literature and patents requested by internal customers, TEMIS said.
Financial terms of the agreement were not released.